{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:02:31Z","timestamp":1784656951551,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12951-015-0082-8","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T20:33:29Z","timestamp":1427229209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model"],"prefix":"10.1186","volume":"13","author":[{"given":"Lubna","family":"Noorani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H","family":"Pourgholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"82_CR1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","volume":"23","author":"DJ Hicklin","year":"2005","unstructured":"Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011\u201327.","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"82_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncol. 2005;69 Suppl 3:4\u201310.","journal-title":"Oncol"},{"key":"82_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10555-011-9337-5","volume":"31","author":"S Masoumi Moghaddam","year":"2012","unstructured":"Masoumi Moghaddam S, Amini A, Morris DL, Pourgholami MH. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev. 2012;31:143\u201362.","journal-title":"Cancer Metastasis Rev"},{"key":"82_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","volume":"80","author":"PJ Paley","year":"1997","unstructured":"Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 1997;80:98\u2013106.","journal-title":"Cancer"},{"key":"82_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<101::AID-IJC2>3.0.CO;2-5","volume":"84","author":"M Orre","year":"1999","unstructured":"Orre M, Rogers PA. VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary. Int J Cancer. 1999;84:101\u20138.","journal-title":"Int J Cancer"},{"key":"82_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10434-999-0373-0","volume":"6","author":"BK Zebrowski","year":"1999","unstructured":"Zebrowski BK, Liu W, Ramirez K, Akagi Y, Mills GB, Ellis LM. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol. 1999;6:373\u20138.","journal-title":"Ann Surg Oncol"},{"key":"82_CR7","first-page":"395","volume":"4","author":"RN Eskander","year":"2012","unstructured":"Eskander RN, Tewari KS. Emerging treatment options for management of malignant ascites in patients with ovarian cancer. Int J Womens Health. 2012;4:395\u2013404.","journal-title":"Int J Womens Health"},{"key":"82_CR8","first-page":"1553","volume":"34","author":"E Smolle","year":"2014","unstructured":"Smolle E, Taucher V, Haybaeck J. Malignant ascites in ovarian cancer and the role of targeted therapeutics. Anticancer Res. 2014;34:1553\u201361.","journal-title":"Anticancer Res"},{"key":"82_CR9","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1158\/1078-0432.CCR-05-0910","volume":"11","author":"L Hu","year":"2005","unstructured":"Hu L, Hofmann J, Holash J, Yancopoulos GD, Sood AK, Jaffe RB. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Clin Cancer Res. 2005;11:6966\u201371.","journal-title":"Clin Cancer Res"},{"key":"82_CR10","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1172\/JCI8829","volume":"105","author":"G Klement","year":"2000","unstructured":"Klement G, Baruchel S, Rak J, Man S, Clark K, Hicklin DJ, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest. 2000;105:R15\u201324.","journal-title":"J Clin Invest"},{"key":"82_CR11","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-05-1181","volume":"12","author":"MH Pourgholami","year":"2006","unstructured":"Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice. Clin Cancer Res. 2006;12:1928\u201335.","journal-title":"Clin Cancer Res"},{"key":"82_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2407-10-143","volume":"10","author":"MH Pourgholami","year":"2010","unstructured":"Pourgholami MH, Cai ZY, Badar S, Wangoo K, Poruchynsky MS, Morris DL. Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole. BMC Cancer. 2010;10:143.","journal-title":"BMC Cancer"},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbrc.2010.06.019","volume":"397","author":"MH Pourgholami","year":"2010","unstructured":"Pourgholami MH, Khachigian LM, Fahmy RG, Badar S, Wang L, Chu SW, et al. Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis. Biochem Biophys Res Commun. 2010;397:729\u201334.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl","key":"82_CR14","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1017\/S0031182000007290","volume":"121","author":"J Horton","year":"2000","unstructured":"Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitol. 2000;121(Suppl):S113\u201332.","journal-title":"Parasitol"},{"key":"82_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3835(01)00382-2","volume":"165","author":"MH Pourgholami","year":"2001","unstructured":"Pourgholami MH, Woon L, Almajd R, Akhter J, Bowery P, Morris DL. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 2001;165:43\u20139.","journal-title":"Cancer Lett"},{"key":"82_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1177\/1933719111398142","volume":"18","author":"EK Choi","year":"2011","unstructured":"Choi EK, Kim SW, Nam EJ, Paek J, Yim GW, Kang MH, et al. Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice. Reprod Sci. 2011;18:763\u201371.","journal-title":"Reprod Sci"},{"key":"82_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2407-13-86","volume":"13","author":"A Ehteda","year":"2013","unstructured":"Ehteda A, Galettis P, Pillai K, Morris DL. Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice. BMC Cancer. 2013;13:86.","journal-title":"BMC Cancer"},{"key":"82_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","volume":"65","author":"H Maeda JW","year":"2000","unstructured":"Maeda JW H, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271\u201384.","journal-title":"J Control Release"},{"key":"82_CR19","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","volume":"12","author":"N Desai","year":"2006","unstructured":"Desai N, Trieu V, Yao Z, Louie L, Ci S, Yang A, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006;12:1317\u201324.","journal-title":"Clin Cancer Res"},{"key":"82_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1586\/ecp.11.7","volume":"4","author":"AJ Montero","year":"2011","unstructured":"Montero AJ, Adams B, Diaz-Montero CM, Gluck S. Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review. Expert Rev Clin Pharmacol. 2011;4:329\u201334.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"82_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jconrel.2011.09.069","volume":"157","author":"B Elsadek","year":"2012","unstructured":"Elsadek B, Kratz F. Impact of albumin on drug delivery\u2013new applications on the horizon. J Control Release. 2012;157:4\u201328.","journal-title":"J Control Release"},{"key":"82_CR22","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1021\/nl301452x","volume":"12","author":"O Akbulut","year":"2012","unstructured":"Akbulut O, Mace CR, Martinez RV, Kumar AA, Nie Z, Patton MR, et al. Separation of nanoparticles in aqueous multiphase systems through centrifugation. Nano Lett. 2012;12:4060\u20134.","journal-title":"Nano Lett"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.6004\/jnccn.2006.0077","volume":"4","author":"P Singhal","year":"2006","unstructured":"Singhal P, Lele S. Intraperitoneal chemotherapy for ovarian cancer: where are we now? J Natl Compr Canc Netw. 2006;4:941\u20136.","journal-title":"J Natl Compr Canc Netw"},{"key":"82_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jps.2600740902","volume":"74","author":"K Hirano","year":"1985","unstructured":"Hirano K, Hunt CA. Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration. J Pharm Sci. 1985;74:915\u201321.","journal-title":"J Pharm Sci"},{"key":"82_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11095-009-0031-z","volume":"27","author":"G Bajaj","year":"2010","unstructured":"Bajaj G, Yeo Y. Drug delivery systems for intraperitoneal therapy. Pharm Res. 2010;27:735\u20138.","journal-title":"Pharm Res"},{"key":"82_CR26","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1023\/A:1012126301290","volume":"14","author":"MP Desai","year":"1997","unstructured":"Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1997;14:1568\u201373.","journal-title":"Pharm Res"},{"key":"82_CR27","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","volume":"26","author":"KY Win","year":"2005","unstructured":"Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26:2713\u201322.","journal-title":"Biomaterials"},{"key":"82_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1166\/jbn.2013.1642","volume":"9","author":"V Uskokovic","year":"2013","unstructured":"Uskokovic V. Entering the era of nanoscience: time to be so small. J Biomed Nanotechnol. 2013;9:1441\u201370.","journal-title":"J Biomed Nanotechnol"},{"key":"82_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens 3rd","year":"2006","unstructured":"Owens 3rd DE, Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93\u2013102.","journal-title":"Int J Pharm"},{"key":"82_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens 3rd","year":"2006","unstructured":"Owens 3rd DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93\u2013102.","journal-title":"Int J Pharm"},{"key":"82_CR31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","volume":"7","author":"ME Davis","year":"2008","unstructured":"Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771\u201382.","journal-title":"Nat Rev Drug Discov"},{"key":"82_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00280-009-1157-8","volume":"65","author":"MH Pourgholami","year":"2010","unstructured":"Pourgholami MH, Szwajcer M, Chin M, Liauw W, Seef J, Galettis P, et al. Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer. Cancer Chemother Pharmacol. 2010;65:597\u2013605.","journal-title":"Cancer Chemother Pharmacol"},{"key":"82_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1470-2045(11)70394-1","volume":"13","author":"G Becker","year":"2012","unstructured":"Becker G, Blum HE. VEGF Trap for the treatment of malignant ascites. Lancet Oncol. 2012;13:115\u20136.","journal-title":"Lancet Oncol"},{"key":"82_CR34","first-page":"5721","volume":"9","author":"AT Byrne","year":"2003","unstructured":"Byrne AT, Ross L, Holash J, Nakanishi M, Hu L, Hofmann JI, et al. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. Clin Cancer Res. 2003;9:5721\u20138.","journal-title":"Clin Cancer Res"},{"key":"82_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrd2591","volume":"9","author":"RA Petros","year":"2010","unstructured":"Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9:615\u201327.","journal-title":"Nat Rev Drug Discov"},{"key":"82_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/bc100070g","volume":"21","author":"H Maeda","year":"2010","unstructured":"Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem. 2010;21:797\u2013802.","journal-title":"Bioconjug Chem"},{"key":"82_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2183\/pjab.88.53","volume":"88","author":"H Maeda","year":"2012","unstructured":"Maeda H. Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88:53\u201371.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"82_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/nbt1340","volume":"25","author":"HS Choi","year":"2007","unstructured":"Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007;25:1165\u201370.","journal-title":"Nat Biotechnol"},{"key":"82_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jconrel.2012.07.013","volume":"164","author":"S Taurin","year":"2012","unstructured":"Taurin S, Nehoff H, Greish K. Anticancer nanomedicine and tumor vascular permeability; where is the missing link? J Control Release. 2012;164:265\u201375.","journal-title":"J Control Release"},{"key":"82_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1756-9966-29-59","volume":"29","author":"J Yin","year":"2010","unstructured":"Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, et al. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res. 2010;29:59.","journal-title":"J Exp Clin Cancer Res"},{"key":"82_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijpharm.2012.04.008","volume":"430","author":"Q Liu","year":"2012","unstructured":"Liu Q, Li R, Zhu Z, Qian X, Guan W, Yu L, et al. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Int J Pharm. 2012;430:350\u20138.","journal-title":"Int J Pharm"},{"key":"82_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1515\/ejnm-2014-0026","volume":"6","author":"L Noorani","year":"2014","unstructured":"Noorani L, Pourgholami MH, Liang M, Morris DL, Stenzel M. Albendazole loaded albumin nanoparticles for ovarian cancer therapy. Eur J of Nanomed. 2014;6:227\u201336.","journal-title":"Eur J of Nanomed"},{"key":"82_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/07357900802210752","volume":"27","author":"MH Pourgholami","year":"2009","unstructured":"Pourgholami MH, Cai ZY, Wang L, Badar S, Links M, Morris DL. Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole. Cancer Invest. 2009;27:171\u20137.","journal-title":"Cancer Invest"},{"key":"82_CR44","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1:1112\u20136.","journal-title":"Nat Protoc"},{"key":"82_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/mp800137z","volume":"6","author":"P Xu","year":"2009","unstructured":"Xu P, Gullotti E, Tong L, Highley CB, Errabelli DR, Hasan T, et al. Intracellular drug delivery by poly (lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm. 2009;6:190\u2013201.","journal-title":"Mol Pharm"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-015-0082-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-015-0082-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-015-0082-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-015-0082-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:48:13Z","timestamp":1630576093000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-015-0082-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1186\/s12951-015-0082-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]},"assertion":[{"value":"23 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}